Mark Cuban on High Drug Prices, Taxing Billionaires, and 2028
Mark Cuban on High Drug Prices, Taxing Billionaires, and 2028
2 hours agoPivotNew York Magazine
Podcast1 hr 15 min
Listen to Episode
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Investors should look for emerging financial products that provide exposure to computing infrastructure and data center yields from chipmakers like Nvidia (NVDA) and AMD (AMD), while accounting for rapid hardware depreciation.

Exercise caution with cryptocurrency holdings like Bitcoin (BTC) and Ethereum (ETH), as both currently demonstrate elevated speculative risk and a failure to function as reliable inflation hedges.

Discount valuations on major healthcare conglomerates and Pharmacy Benefit Managers—including UnitedHealth Group (UNH), The Cigna Group (CI), and CVS Health (CVS)—to protect against regulatory scrutiny and employer audits targeting hidden rebate margins.

Monitor Costco Wholesale Corporation (COST) as an attractive retail play that is leveraging new co-branded Medicare partnerships to boost customer retention and higher-margin health service sales.

Approach media stocks like Paramount (PARA) cautiously until direct-to-consumer streaming profits and reduced subscriber churn clearly justify the rising costs of live sports broadcast contracts.

Detailed Analysis

AI Semiconductor Chips (NVDA, AMD)

  • Mark Cuban proposed that computing chips (such as those from Nvidia (NVDA), AMD (AMD), Google (GOOGL) TPUs, and custom silicon from Amazon (AMZN) and Apple (AAPL)) are emerging as a new real-world asset class.
    • He compared high-demand processing chips to real estate apartments: they generate maximum rental yield when brand new and gradually decline in value as newer iterations appear.
    • Cuban highlighted the potential for financial contracts and real-world asset (RWA) tokenization, allowing investors to trade rights to the revenue generated by computing power.

Takeaways

  • Look for emerging financial products that allow exposure to computational infrastructure and data center revenue streams, while accounting for the natural depreciation cycle of hardware.

Bitcoin (BTC) & Ethereum (ETH)

  • Cuban stated that he has sold most of his Bitcoin (BTC), arguing the asset has "lost the plot" by failing to act as a hedge against inflation, currency devaluation, and geopolitical instability despite significant macroeconomic uncertainty.
  • Expressed disappointment in Ethereum (ETH), stating that smart contracts have largely fueled low-barrier, copycat blockchains and speculative tokens rather than sustainable real-world applications.
  • Warned that meme coins and speculative cryptocurrencies represent a game of "musical chairs" with zero intrinsic margin of safety.

Takeaways

  • Be cautious when treating Bitcoin strictly as an inflation hedge or "digital gold," as its price action remains largely driven by speculative narrative and liquidity rather than dividend or cash flow fundamentals.

Healthcare Conglomerates & PBMs (UNH, CI, CVS)

  • Cuban strongly criticized large healthcare conglomerates and Pharmacy Benefit Managers (PBMs)—including UnitedHealth Group (UNH), The Cigna Group (CI), and CVS Health (CVS) / Express Scripts—for inflating costs through lack of pricing transparency, formulary manipulation, and complex rebate structures.
  • Argued that employers and self-insured companies (representing 67% of employer-insured workers) can cut massive operational costs by auditing long-form PBM contracts using artificial intelligence to detect hidden fees and exclusions.
  • Called for public investors to demand funds divest from major insurance carriers that prioritize earnings growth over price transparency.

Takeaways

  • Factor regulatory and antitrust risk into valuations of major PBM-linked healthcare stocks, as legislative pressure and corporate contract audits threaten existing pricing and rebate margins.

Costco Wholesale Corporation (COST)

  • Costco has entered the Medicare space through a partnership with Scan Group to offer Costco-branded Medicare Advantage and supplemental plans in select states.
    • The plans are designed to package Costco offerings, such as over-the-counter medications, prescription drugs, and vision/hearing products.
  • Cuban characterized the move primarily as a sales and marketing initiative rather than a fundamental solution to healthcare delivery, though he noted Costco's brand trust and efficiency could yield incremental retail consumer savings.

Takeaways

  • Monitor Costco's healthcare initiatives as an ancillary driver for member retention and cross-selling higher-margin optical, hearing, and retail health services.

Media Companies & Sports Assets (PARA)

  • Highlighted that soaring sports franchise valuations (such as the proposed $12.5 billion valuation for the Los Angeles Lakers) are heavily reliant on private equity participation, arena real estate development, and massive broadcast rights fees.
  • Cuban noted that sports rights agreements depend entirely on whether streaming services—such as Paramount+ (PARA)—can successfully add subscribers and reduce customer churn to justify escalating multi-billion-dollar contract costs.
    • If streaming networks cannot monetize these sports packages, rights fees will face downward pressure, directly threatening team cash flows and over-leveraged franchise valuations.

Takeaways

  • Assess the sustainability of sports-heavy media companies like Paramount (PARA) based on their ability to convert live sports rights into lower subscriber churn and direct-to-consumer profitability.
Ask about this postAnswers are grounded in this post's content.
Episode Description
Scott-Free August continues, and Kara sits down with Mark Cuban — entrepreneur and co-founder of Cost Plus Drugs. They dig into why prescription drug prices are finally falling, Cuban's war with the healthcare industry, and Costco's surprising Medicare play. Then: why Cuban thinks chips are the new crypto, and California's controversial billionaire tax. Plus — will Cuban actually run for president? Learn more about your ad choices. Visit podcastchoices.com/adchoices
About Pivot
Pivot

Pivot

By New York Magazine

Every Tuesday and Friday, tech journalist Kara Swisher and NYU Professor Scott Galloway offer sharp, unfiltered insights into the biggest stories in tech, business, and politics. They make bold predictions, pick winners and losers, and bicker and banter like no one else. After all, with great power comes great scrutiny. From New York Magazine and the Vox Media Podcast Network.